Biossance
launched by biotech firm Amyris in 2016, commercialized lab-made bio-identical squalane fermented from sugarcane-derived sucrose using engineered Saccharomyces cerevisiae, positioning "clean beauty" as scientifically rigorous rather than purely natural-marketing-driven.
- Country
- United States
bio-squalane
us
Coverage
| CN | EU | US | |
|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ |
Regulatorsfdanmpareach
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Cosmetics, nutricosmetics & wellness | specialty-fine-chem | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.